Use of computerized health claims data to monitor compliance with antibiotic prophylaxis in sickle cell disease

Pharmacoepidemiology and Drug Safety

Volumn 7, Issue 2, 1998, Pages 107-112

  Davis, Harold ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Health services research; Patient compliance; Penicillins; Sickle cell anemia

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; COMPUTER ANALYSIS; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEDICAID; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STREPTOCOCCUS INFECTION;

EID: 0031800195     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199803/04)7:2<107::AID-PDS323>3.0.CO;2-G     Document Type: Article

References (18)

1. Robinson, M. G. and Watson, R. J. Pneumococcal meningitis in sickle-cell anemia. New England Journal of Medicine 1966; 274: 1006-1008.
2. Eeckels, R., Gatti, F. and Renoirite, A. M. Abnormal distribution of haemoglobin genotypes in Negro children with severe bacterial infections. Nature 1967; 216: 382.
3. Kabins, S. A. and Lerner, C. Fulminant pneumococcemia and sickle cell anemia. Journal of the American Medical Association 1970; 211: 467-471.
4. Lane, P. A., Rogers, Z. R., Woods, G. M., et al. Fatal pneumococcal septicemia in hemoglobin SC disease. Journal of Pediatrics 1994 124: 859-862.
5. Zarkowsky, H. S., Gallagher, D., Gill, E. M., et al. Bacteremia in sickle hemoglobinopathies. Journal of Pediatrics 1986; 109: 579-585.
6. Leikin, S. L., Gallagher, D., Kinney, T. R., et al. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989; 84: 500-508.
7. Gaston, M., Verter, J. I., Wood, G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. New England Journal of Medicine 1986; 314: 1593-1599.
8. Sickle Cell Disease Guideline Panel. Sickle Cell Disease Screening, Diagnosis Management and Counseling in Newborns and Infants. Clinical Practice Guideline No. 6. AHCPR Pub. No. 93-0562. Agency for Health Care Policy and Research, Public Health Service, Department of Health and Human Services, Rockville, MD, April 1993.
9. Gaston, M. H. and Reid, C. D. Infection in sickle cell disease. In Sickle Cell Disease: Pathophysiology Diagnosis, and Management. Mankad, V. N. and Moore, R. B., (Eds) Praeger, Westport, CT, 1992, pp. 271-299.
10. Lane, P. A., O'Connell, J. L., Lear, J. L., et al. Functional asplenia in hemoglobin SC disease. Blood 1995; 85; 2238-2244.
11. Buchanan, G. R., Siegel, J. D., Smith, S. J. and DePasse, B. M. Oral penicillin prophylaxis in children with impaired splenic function: a study in compliance. Pediatrics 1982; 70: 926-930.
12. Pegelow, C. H., Armstrong, E. D., Light, S., Toledano, S. R. and Davis, J. Experience with the use of prophylactic penicillin in children with sickle cell anemia. Pediatrics 1991; 118: 736-738.
13. Gerson. A. C., Pegelow, C. H., Armstrong, F. D. and Faust, J. The efficacy of an intervention to increase maternal adherence to prophylactic penicillin. In: Proceedings of 17th Annual Sickle Cell Disease Program Conference, 14 March 1992, Nashville, Tennessee. Meharry Medical College, Nashville, Tennessee, p. 64a.
14. Verghese, K. P., Scott, R. B., Teixeira, G. and Ferguson, A. D. Studies in growth and development, XII: physical growth of North American Negro children. Pediatrics 1969; 44: 243-247.
15. Platt, O., Rosenstock, W. and Espeland, M. A. Influence of sickle hemoglobinopathies on growth and development. New England Journal of Medicine 1984; 311: 7-12.
16. Physicians' Desk Reference. Medical Economics, Montvale, New Jersey, 1996.
17. Jaffe, J. M., Certo, N. M., Pirakitikulr, P. and Colaizzi, J. L. Stability of several brands of ampicillin and penicillin V potassium oral liquids following reconstitution. American Journal of Hospital Pharmacy 1976; 33: 1005-1010.
18. Davis, H., Moore, R. M. and Gergen, P. J. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Reports 1997; 112: 40-43.